Biosimilars Forum, Biosimilars Council urge Congressional action on biosimilars
Congress must prioritize the use of safe, effective and lower-cost biosimilars to address America’s skyrocketing prescription drug costs, Biosimilars Forum's executive director Juliana Reed said.